SARA GLEASMAN-DESIMONE: Open Payments
NPI 1841284064 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 10 payments from 6 companies in 2025. Trend: 2023 $110 · 2024 $347 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $286 |
| Phathom Pharmaceuticals, Inc. | 2 | $135 |
| Gilead Sciences, Inc. | 2 | $134 |
| GENZYME CORPORATION | 1 | $122 |
| Grifols USA, LLC | 1 | $103 |
| ABBVIE INC. | 2 | $41 |
Products named: REZDIFFRA, VOQUEZNA, DUPIXENT, Livdelzi, Prolastin-C Liquid, RINVOQ, SKYRIZI.
Industry payments across NY — which companies pay providers there.
